by Bonnell Foundation | Feb 13, 2018 | News
February 12, 2018 — Vertex announced that the U.S. FDA approved SYMDEKO (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of cystic fibrosis (CF) in people ages 12 and older who have two copies of...
by Bonnell Foundation | Feb 5, 2018 | News
January 31, 2018 — Vertex announced the selection of two next-generation correctors, VX-659 and VX-445, to advance into Phase 3 development as part of two different triple combination regimens for people with cystic fibrosis (CF). This decision was based on...
by Bonnell Foundation | Jan 9, 2017 | Media/Press
Raising awareness about the importance of access to care for CF patients & their families Jan. 9, 2017 (Southfield, MI) – The Bonnell Foundation today announced an important upcoming collaborative summit to spotlight cystic fibrosis (CF) and raise awareness about...
by Bonnell Foundation | Aug 29, 2016 | Inspirational Stories
As a young boy growing up I always had breathing problems. My parents said I had Asthma and was treated for that on a daily basis but I still had many health issues. My mother who was a nurse saw that I got the medical care. I was tested with a sweat gland test but...
